Navigation Links
New Medicare model guidelines for benefit years 2012-2014 in development
Date:10/4/2010

Rockville, Md., October 4, 2010 As the Medicare Model Guidelinesa listing of therapeutic categories and pharmacologic classes that Medicare Part D plans can utilize when developing their formulariesundergo revision for the first time in three years, the U.S. Pharmacopeial Convention (USP) is announcing its revision schedule and the expanded opportunities for public input as it develops Version 5.0.

Medicare Model Guidelines Version 5.0 will be available for utilization by prescription drug plans for the plan years 2012�. USP, a nonprofit scientific organization that sets federally recognized standards for the quality of medicines, was charged with developing the guidelines for the Centers for Medicare and Medicaid Services (CMS) under the Medicare Prescription Drug Improvement and Modernization Act of 2003.

USP has maintained a public comment process and one-on-one manufacturer consultations for developing the USP Model Guidelines since the beginning of this activity in 2004. In this revision cycle, USP is initiating new public Open Microphone Web meetings to solicit specific feedback on the content and organization of the USP Model Guidelines (to be held November 4, 8, 11 and 16, 2010). The one-on-one manufacturer consultations will be held October 4󈝿, 2010, and are an opportunity for manufacturers to schedule 30-minute scientific and clinical presentations with USP scientific staff to present information related to their medicines. Information related to these activities can be found on www.usp.org, under "Model Guidelines."

The Medicare Model Guidelines, which were initially released annually, will be developed by the USP Model Guidelines Expert Panel consisting of clinical pharmacists and pharmacologists, formulary specialists, health care practitioners and academicians, providers, beneficiaries and other volunteer experts. The panel will deliberate on the categories and classes to be included in Version 5.0 to be used as a resource by drug plans, reviewing current scientific evidence related to newly approved drugs and indications.

The Expert Panel will release the draft USP Model Guidelines Version 5.0 for public comment through the USP Web site (www.usp.org) on November 1, 2010, commencing a 30-day public comment period closing November 30, 2010. The draft USP Model Guidelines Version 5.0 will be presented to USP's Nomenclature, Safety and Labeling Expert Committee, the Expert Committee to which the Expert Panel reports, for approval in mid-January 2011. The final USP Medicare Model Guidelines Version 5.0 will be presented to CMS in late January 2011, and posted on the USP Web site in early February 2011.


'/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. Medicare Cost-Saving Moves Can Backfire
2. Connecture, Inc. Announces Partnership with MedicareCRM
3. Medicare data reveals differences in orthopedic surgical outcomes
4. Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC)
5. Georgia Senators Urged to Stop Medicare Cut Before March 1 Deadline
6. Top-Rated Medicare Advantage Plan Reaches 27,000-Member Milestone
7. Pelosi Statement on Additional Aid to States In Medicare Part D Payments
8. Medicare Advantage Members May Make Changes During Open Enrollment
9. Partners Home Care Scores in Top Tier in National Medicare Demonstration Project
10. Study Suggests Low-Consuming Medicare Beneficiaries With Chronic Disease Are More Costly to Program
11. Senate Inaction On Medicare Hurts Seniors, Military and Boomers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... New York (PRWEB) , ... May 23, 2017 ... ... NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, to provide ... Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: